Antischistosomal and Immune Enhancing Potential of Azadirachta Indica and Ekebergia Capensis in Mice Infected with Schistosoma Mansoni

Show simple item record

dc.contributor.author Musili, Rael Mueni
dc.date.accessioned 2017-06-05T10:32:23Z
dc.date.available 2017-06-05T10:32:23Z
dc.date.issued 2017-06-05
dc.identifier.uri http://hdl.handle.net/123456789/3277
dc.description.abstract Schistosomiasis is a parasitic disease of great socio-economic and public health importance in tropical and sub-tropical countries. Praziquantel (PZQ) is effective against all schistosome species, it is ineffective on larval stages and concerns of drug resistant strains developing prompts the need for alternative antischistosomal drugs. Plants have over the years provided a rich source of novel drugs for a wide range of diseases afflicting man and domestic animals. Swiss albino mice were infected with 90 cercariae each and treated orally with aqueous extracts of Ekebergia capensis or Azadirachta indica at doses of 25, 50, 100, 200 and 400 mg/kg at 2 weeks (juvenile worms), 4 weeks (immature worms) and 7 weeks (adult worms) post infection. Total reduction of worm and egg loads was used as an indicator of drug activity, relative to the infected but untreated control groups. Both E. capensis and A. indica showed significant dose-dependent percentage worm load reduction (P<0.05) at different doses ranging from 100 mg/kg to 400 mg/kg. These extracts also significantly reduced tissues (liver and intestine) egg load counts at doses ranging from 50 mg/kg to 400 mg/kg which was also dose-dependent. E. capensis was more potent than A. indica in reducing both the worm burden at all the stages and tissue egg load (P<0.05). Immune enhancing potential of the medicinal plants was determined by analyzing the levels of cytokines in serum samples that were collected before and after treatment. A BD-Cytometric Bead Array (CBA) mouse Th1/Th2/Th17 kit was used to quantitate the levels of cytokines using flow cytometer (FACS Calibur) and analysis of the data was done using FCAP software. Results from two doses (400mg/kg and 200mg/kg) in 2 weeks and 7 weeks pi experiments (to represent juvenile and adult worms respectively) indicated that the two medicinal plant extracts have immunomodulatory effect. There was a significant increase (P<0.05) in Th1 cytokines (IL-2, IFN- γ and TNF-α), a decrease in Th2 cytokines (IL-4, IL-6 and IL-10) and an increase in Th17 (IL-17) following treatment with the plant extract at both 2 weeks and 7 weeks pi. These findings confirm the potential use of medicinal plants in the management of schistosomiasis. en_US
dc.description.sponsorship Dr. Kimani Gachuhi, KEMRI, KENYA Prof. Zipporah Ng’ang’a, PhD JKUAT, KENYA en_US
dc.language.iso en en_US
dc.publisher COHES, JKUAT en_US
dc.subject Antischistosomal Potential of Azadirachta en_US
dc.subject Immune Enhancing en_US
dc.subject Potential of Azadirachta en_US
dc.subject Azadirachta Indica en_US
dc.subject Ekebergia Capensis en_US
dc.subject Schistosoma Mansoni en_US
dc.subject JKUAT en_US
dc.subject Kenya en_US
dc.subject Molecular Medicine en_US
dc.subject Msc Molecular Medicine en_US
dc.title Antischistosomal and Immune Enhancing Potential of Azadirachta Indica and Ekebergia Capensis in Mice Infected with Schistosoma Mansoni en_US
dc.type Thesis en_US


Files in this item

This item appears in the following Collection(s)

  • College of Health Sciences (COHES) [755]
    Medical Laboratory; Agriculture & environmental Biotecthology; Biochemistry; Molecular Medicine, Applied Epidemiology; Medicinal PhytochemistryPublic Health;

Show simple item record

Search DSpace


Browse

My Account